1. OA LOXO-292, a Potent, Highly Selective RET Inhibitor, in MKI-Resistant RET Fusion-Positive Lung Cancer Patients with and without Brain Metastases 
V. Velcheti, T. Bauer, V. Subbiah, M. Cabanillas, N. Lakhani, L. Wirth, G. Oxnard, M. Shah, E. Sherman, S. Smith, T. Eary, S. Cruickshank, B. Tuch, K. Ebata, M. Nguyen, S. Corsi-Travali, S. Rothenberg, A. Drilon 
Journal of Thoracic Oncology 
Volume 12, Issue 11, (November 2017)
DOI: /j.jtho
Copyright © Terms and Conditions

2. Journal of Thoracic Oncology 2017 12, DOI: (10. 1016/j. jtho. 2017. 09
Copyright © Terms and Conditions